Search research articles
Contact Us
Filters
Showing results (271-280 of 277) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 277 results.
Nature Microbiology
|
March 30, 2024
Preclinical evaluation of the SARS-CoV-2 M<sup>pro</sup> inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir
Xiaoxin Chen, Xiaodong Huang, Qinhai Ma, et al.
Med (New York, N.Y.)
|
December 9, 2023
Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus
Wenda Guan, Rong Qu, Lihan Shen, et al.
Journal of Thoracic Disease
|
May 22, 2025
Application of novel dark-quencher labeled probes in multiplex qRT-PCR assays for rapid detection of SARS-CoV-2 variants
Zhiqi Zeng, Jie Yang, Jun Dai, et al.
Eclinicalmedicine
|
April 15, 2024
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trial
Hongzhou Lu, George Zhang, John Mao, et al.
Eclinicalmedicine
|
January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial
Yangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Nature
|
November 19, 2020
Publisher Correction: Exuberant fibroblast activity compromises lung function via ADAMTS4
David F Boyd, E Kaitlynn Allen, Adrienne G Randolph, et al.
Nature
|
October 29, 2020
Exuberant fibroblast activity compromises lung function via ADAMTS4
David F Boyd, E Kaitlynn Allen, Adrienne G Randolph, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 277) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 277 results.
Nature Microbiology
|
March 30, 2024
Preclinical evaluation of the SARS-CoV-2 M<sup>pro</sup> inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir
Xiaoxin Chen, Xiaodong Huang, Qinhai Ma, et al.
Med (New York, N.Y.)
|
December 9, 2023
Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus
Wenda Guan, Rong Qu, Lihan Shen, et al.
Journal of Thoracic Disease
|
May 22, 2025
Application of novel dark-quencher labeled probes in multiplex qRT-PCR assays for rapid detection of SARS-CoV-2 variants
Zhiqi Zeng, Jie Yang, Jun Dai, et al.
Eclinicalmedicine
|
April 15, 2024
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trial
Hongzhou Lu, George Zhang, John Mao, et al.
Eclinicalmedicine
|
January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial
Yangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Nature
|
November 19, 2020
Publisher Correction: Exuberant fibroblast activity compromises lung function via ADAMTS4
David F Boyd, E Kaitlynn Allen, Adrienne G Randolph, et al.
Nature
|
October 29, 2020
Exuberant fibroblast activity compromises lung function via ADAMTS4
David F Boyd, E Kaitlynn Allen, Adrienne G Randolph, et al.
Page
of 28